Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain

Psychiatry Research

Volumn 60, Issue 2-3, 1996, Pages 91-99

  Bartlett, Elsa J ^a   Brodie, Jonathan D ^a   Simkowitz, Philip ^a   Dewey, Stephen L ^b   Rusinek, Henry ^a   Volkow, Nora D ^b   Wolf, Alfred P ^b   Smith, Gwenn ^a   Wolkin, Adam ^a   Cancro, Robert ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Cerebral metabolism; Dopamine receptors; Neuroleptics; Positron emission tomography; Schizophrenia

Indexed keywords

DOPAMINE RECEPTOR; HALOPERIDOL;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENERGY METABOLISM; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VOLUNTEER;

EID: 0030010280     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02711-4     Document Type: Article

References (34)

1. Andreasen, N.C., Rezai, K., Alliger, R., Swayze, V.W., Flaum, M., Kirchner, P., Cohen, G. and O'Leary, D.S. (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 49, 943-958.
2. Bartlett, E.J., Brodie, J.D., Simkowitz, P., Dewey, S.L., Rusinek, H., Wolf, A.P., Volkow, N.D., Smith, G., Wolkin, A. and Cancro, R. (1994) Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151, 681-686.
3. Bartlett, E.J., Brodie, J.D., Wolf, A.P., Christman, D.R., Laska, E. and Meissner, M. (1988) Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8, 502-512.
4. Buchsbaum, M.S., Haier, R.J., Potkin, S.G., Nuechterlein, K., Bracha, H.S., Katz, M., Lohr, J., Wu, J., Lottenberg, S. and Jerabek, P.A. (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49, 935-942.
5. Chabrol, H., Guell, A., Bes, A. and Moron P. (1986) Cerebral blood flow in schizophrenic adolescents. Am J Psychiatry 143, 130.
6. Cleghorn, J.M., Garnett, E.S., Nahmias, C., Firman, G., Brown, G.M., Kaplan, R.D., Szechtman, H. and Szechtman, B. (1989) Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 28, 119-133.
7. Cohen, R.M., Semple, W.E., Gross, M., Nordahl, T.E., DeLisi, L.E., Holcomb, H.H., King, A.C., Morihisa, J.M. and Pickar, D. (1987) Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci 20, 2031-2039.
8. 2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy resistant schizophrenic patients. Biol Psychiatry 29, 629-634.
9. DeLisi, L.E., Holcomb, H.H., Cohen, R.M., Pickar, D., Carpenter, W., Morihisa, J.M., King, A.C., Kessler, R. and Buchsbaum, M.S. (1985) Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab 5, 201-206.
10. Early, T.S., Reiman, E.M., Raichle, M.E. and Spitznagel, E.L. (1987) Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci U S A 84, 561-563.
11. Fox, P.T. and Raichle, M.E. (1985) Stimulus rate determines regional brain blood flow in striate cortex. Ann Neurol 17, 303-305.
12. Friedhoff, A.J. (1986) A dopamine dependent restitutive system for the maintenance of mental normalcy. Ann N Y Acad Sci 463, 47-52.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopoly-ether supported nucleophilic substitution. J Nucl Med 27, 235-238.
14. Huang, S.-C., Phelps, M.E., Hoffman, E.J., Sideria, K., Selin, C.J. and Kuhl, D.E. (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238, E69-E82.
15. Leigh, T.J., Link, C.G.G. and Fell, G.L. (1992) Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG. Br J Clin Pharmacol 34, 65-70.
16. Magliozzi, J.R., Mungas, D., Laubly, J.N. and Blunden, D. (1989) Effect of haloperidol on a symbol digit substitution task in normal adult males. Neuropsychopharmacology 2, 29-37.
17. Matsui, T. and Hirano, H. (1978) An Atlas of the Human Brain for Computerized Tomography. Igaku-Shoin, Tokyo.
18. McClelland, G.R., Cooper, S.M. and Pilgrin, A.J. (1990) A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers. Br J Clin Pharmacol 30, 795-803.
19. McCulloch, J., Savaki, H. and Sokoloff, L. (1982) Distribution of effects of haloperidol on energy metabolism in the conscious rat: relation to pharmacokinetics. J Neurochem 43, 724-732.
20. Miller, R. (1987) The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness. Psychopharmacology 92, 405-415.
21. 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106, 433-438.
22. Pelizzari, C.A., Chen, G.T.Y., Spelbring, D.R., Weichselbaum, R.R. and Chen, C. (1989) Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 13, 20-26.
23. Peroutka, S.J. and Snyder, S.H. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137, 1518-1522.
24. Phelps, M.E., Mazziotta, J.C., Kuhl, D.E., Nuwer, M., Packwood, J., Metter, J. and Engel, J., Jr. (1981) Tomographic mapping of human cerebral metabolism during visual stimulation and deprivation. Neurology 31, 517-529.
25. 11C]deoxyglucose. J Cereb Blood Flow Metab 5, 179-192.
26. Rusinek, H., Tsui, W.-H., Levy, A.V., Noz, M.E. and deLeon, M. (1993) Principal axes and surface fitting methods for three-dimensional image registration. J Nucl Med 34, 2019-2024.
27. Saletu, B., Grunberger, J. and Linzmayer, L. (1983a) Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG and psychometric studies: Part I. Int J Clin Pharmacol Ther Toxicol 21, 489-495.
28. Saletu, B., Grunberger, J. and Linzmayer, L. (1933b) Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG and psychometric studies: Part H. Int J Clin Pharmacol Ther Toxicol 21, 544-551.
29. 14C]deoxyglucose method for measurement of local cerebral glucose utilization: theory, procedures and normal values in the conscious and anesthetized albino rat. J Neurochem 28, 897-916.
30. Tamminga, C.A., Holcomb, H.H., Gastineau, E. and Medoff, D. (1992) Striato-thalamo-cortical circuit for haloperidol action in vivo in human brain: PET/FDG analysis. Soc Neurosci Abstr 18, 317.
31. Weissman, A.D., Su, T.P., Hedreen, J.C. and London, E.D. (1988) Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther 247, 29-33.
32. Wilkinson, L. (1990) SYSTAT: The System for Statistics. Systat, Inc., Evanston, IL.
33. Wolkin, A., Barouche, F., Wolf, A.P., Rotrosen, J., Fowler, J.S., Chiue, C.Y., Cooper, T.B. and Brodie, J.D. (1989) Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. Am J Psychiatry 146, 905-908.
34. Wolkin, A., Jaeger, J., Brodie, J.D., Wolf, A.P., Fowler, J., Rotrosen, J., Gomez-Mont, F. and Cancro, R. (1985) Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 142, 564-571.